Dose Escalation Study to Evaluate the Safety and Tolerability of Multiple Infusions of BPS804 in Adults With Hypophosphatasia (HPP)

Mise à jour : Il y a 4 ans
Référence : NCT01406977

Femme et Homme

  • | Pays :
  • Germany
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The purpose of the study is to determine tolerability, PK/PD and preliminary efficacy of BPS804 in adult patients with HPP treated with multiple escalating doses of BPS804. This study will allow a comparison of several doses of the study drug within the first two weeks after administration and after a longer assessment period for the highest dose level to enable selection of dose ranges to be tested in subsequent studies in the HPP indication.


Critère d'inclusion

  • Hypophosphatasia

Liens